In Brief Nasca et al. demonstrate that stress differentially regulates glutamate homeostasis in the dorsal and ventral hippocampus and identify a mechanism by which buffering histone acetylation protects the stress-sensitive ventral dentate gyrus to promote resilience and antidepressant responses via epigenetic programming of an xCT-mGlu2 gene network.
INTRODUCTION
A chronic excess of glutamate, the most widely distributed excitatory neurotransmitter in the CNS, is among the pathogenic mechanisms associated with a loss of resilience to stress Nasca et al., 2015a ) that leads to development of stress-related mental disorders, including depression (Popoli et al., 2011) . A unique feature of the glutamatergic system is the scarcity of enzymes to significantly degrade glutamate. Indeed, glutamate homeostasis is mainly mediated by glutamate receptors, exchangers, and transporters that are directly involved in its release and reuptake (Lapidus et al., 2013; Popoli et al., 2011) . Therefore, glutamate genes are logical targets to develop novel therapeutic strategies with improved efficacy (Nicoletti et al., 2015) . For example, glutamate pre-and post-synaptic neuronal receptors are now interesting targets of investigation (Krystal et al., 2002) . Both ketamine and acetyl-L-carnitine (LAC), which, respectively, interfere with post-synaptic NMDA receptors and the putative pre-synaptic mGlu2 receptors (inhibitors of glutamate release) have been shown to exert rapid antidepressant-like effects in several animal models (Nasca et al., 2013b; Zarate et al., 2010) , including stress-induced phenotypes.
Yet, emerging evidence has begun to elucidate the role of other glutamate markers, such as the cystine-glutamate exchanger (xc-) in the homeostatic control of the glutamate synapse (Kalivas, 2009; Mahler et al., 2014; Massie et al., 2015) . The system xc-is mainly expressed in astroglial cells and its catalic subunit xCT acts as a regulator of glutamate homeostasis. xCT mediates non-vesicular release of glutamate from astrocytes and microglia to maintain glutamate concentration at physiological levels in a 1:1 exchange of cystine for glutamate (Kalivas, 2009) . The glial glutamate released by xc-to the periterminal axon activates a network that is known to include Glt-1 transporters (pharmacological targets for reducing cue-induced cocaine reinstatement) by priming Glt-1 to buffer glutamate levels (Reissner et al., 2015) . Previous studies have shown that xCT-mediated release of glutamate to the periterminal axon also involves activation of mGlu2 receptors-markers of stress susceptibility ) and targets of next-generation antidepressant candidates (Nasca et al., 2013b; Russo and Charney, 2013) -by priming mGlu2 receptors to inhibit neuronal glutamate release (Lewerenz et al., 2013) .
A critical epigenetic mechanism of environmental-driven regulation of gene expression is acetylation of histones (Jenuwein and Allis, 2001 ). This is a mechanism by which gene transcription is turned on/off by adding/removing acetyl groups to the lysine on the histone N-terminal tails (Jenuwein and Allis, 2001 ). For example, previous studies have shown a stress-driven acetylation of histone-3-lysine-27 (H3K27) in the regulation of the transcription of glutamate genes, such as mGlu2 receptors (Nasca et al., 2013b) . Notably, preclinical and clinical findings have shown that acetylation of histones is a reversible modification, providing a target for next-generation therapeutics with acetylating properties to regulate gene expression (Flight, 2013; Kurita et al., 2012; Nasca et al., 2013b; Russo and Charney, 2013; Sun et al., 2013) . Several decades of research have characterized gene expression changes and started to elucidate mechanisms of histone acetylation in one of the most stress-sensitive brain regions, the hippocampus. However, very little is known about how stress affects gene expression, including glutamate markers, along the dorso-ventral axis of the hippocampus. This is particularly relevant in view of recent findings in which the ventral hippocampus has emerged as a target of antidepressants with functions distinctly different from that of the dorsal hippocampus that is more involved in context discrimination (Kheirbek and Hen, 2011) .
Here, we investigated stress effects upon glutamatergic regulation across the dorso-ventral axis of the hippocampus and studied the role of xCT in resilience to stress.
RESULTS
Prolonged Stress Decreases xCT in the Ventral DG and Leads to Loss of Resilience: Importance of Distinguishing between Dorsal and Ventral Hippocampus We began by screening gene expression for several members of the glutamate synapse ( Figure 1C ) after stress paradigms of different intensities and durations ( Figure 1A) . After a single episode of acute restraint stress (ARS), gene expression profiling within the whole hippocampus showed rapid changes in the glutamate exchangers xCT, transporters Glt-1, metabotropic glutamate receptors mGlu2, mGlu3, and mGlu5, and ionotropic glutamate receptors NR1/NMDA ( Figure 1A ). This pattern after ARS is suggestive of an increased glutamatergic activity that is in line with previous evidence showing that a single episode of stress increases extrasynaptic glutamate (Lowy et al., 1993) . ARS-increased phosphorylation of the cyclic AMP response element binding protein (CREB), which is positively regulated by glutamate (Mao et al., 2004) (Figure S1 ), further supports an increased glutamatergic activity in hippocampus after ARS.
In response to 7-and 14-day sub-chronic restraint stress (sub-CRS), we found no change in the gene expression profiles of mGlu2, mGlu3, mGlu5, and NR1/NMDA receptors that remained at the same baseline as control non-stressed group, suggesting an adaptation of glutamatergic system to more enduring environmental stressors. Yet, 7-and 14-day sub-CRS led to an upregulation of xCT exchangers and Glt-1 transporters. This shows that the effects of 7-and 14-day sub-CRS led to states that do not represent a return to the naive-baseline, but rather a new state in which reactivity to further stress produces a novel expression profile with tighter regulation of glutamate reuptake and release (Figure 1A) .
We then employed a more prolonged stress, 21-day CRS, a duration that has been demonstrated to cause dendritic remodeling in mood regulatory brain regions, such as the CA3 (Magariñ os and McEwen, 1995) and basolateral and medial amygdala (Lau et al., 2017) . After CRS, the glutamatergic gene expression profile in the hippocampus showed a strong habituation in all the glutamate genes, except for a downregulation of mGlu2 expression ( Figure 1A ), which has been previously identified as a marker of depression-and anxiety-like behaviors (Nasca et al., 2013b . Indeed, 21-day CRS resulted in increased immobility at the forced swim test (FST), a behavioral measure of copying style and a surrogate for psychomotor retardation; such a behavioral phenotype was not observed either after ARS or 7-or 14-day sub-CRS using the same behavioral test ( Figure 1B ). CRS also resulted in decreased social interactions, reinforcing the occurrence of depressive-like behavior after prolonged CRS ( Figure S2 ).
Next, we determined how CRS, which led to depressive-like behavior ( Figure 1B ; Figure S2 ), affected glutamatergic regulation in dorsal versus ventral hippocampus (dHipp versus vHipp, Figure 1D ). First, we validated our micro-dissection approach by examining the expression of a gene, lactase (LCT: 723.9 ± 52.2 in dHipp, 100 ± 93.2 in vHipp expressed as % vHipp), which is known to be poorly expressed in the vHipp (Kirby et al., 2013) . Within the dHipp, we found that CRS caused substantial habituation, underscored by the lack of changes in all the glutamate genes here analyzed, except for an increase in Glt-1 and NR1/NMDA receptors ( Figure 1E ). Such an increase in NMDA receptors is suggestive of an increased responsiveness of the glutamate system that is counteracted by the upregulation of Glt-1 transporters, which clear glutamate from the synaptic space. The lack of changes in xCT exchangers and increased immobility time at the forced-swim test as compared to age-matched not-stressed mice (one-way ANOVA repeated-measures F4,52 = 0.74, p = 0.57 [time] ; F1,13 = 2.43, p = 0.14 [stress]; F4,52 = 2.89, p < 0.05 [interaction] ). CRS also led to impaired SIs ( Figure S2 ). (D and E) CRS led to a substantial habituation within the dorsal hippocampus (dHipp, D) with no changes in all glutamate genes, except for upregulation of NR1/ NMDA receptors and Glt-1 transporters, which exert opposite functions on glutamate homeostasis (E). (D and F) In contrast, CRS led to dysregulated glutamatergic activity in the ventral hippocampus (vHipp, D) with downregulation of mGlu2, mGlu3 and xCT transcripts (F). (G) Representative 403 confocal images of hippocampal vDG sections showing xCT, DAPI, and merged immunofluorescence from not-stressed mice (top) and CRS mice (bottom). (H-K) Immunofluorescence (H and J) and immunohistochemistry (I and K) approaches show that CRS reductions of xCT and mGlu2 expression were narrowed to the ventral dentate gyrus (vDG). Bars represent mean ± SEM, and asterisk indicates significant comparisons with corresponding controls, *p < 0.05, **p < 0.01, ***p < 0.001 at Student's two-tailed t tests. Representative brain sections in (D) are available from 2015 Allen Institute for Brain Science. Allen Mouse Brain Atlas (Lein et al., 2007) . Green and red signs above bars indicate putative glutamate homeostasis (up, down, and equal); green and red colors indicate adaptive and maladaptive behavioral outcomes in terms of depressive-like behaviors (see also B). Scale bar, 1 mm. See also Figures S1, S2 , and S3. mGlu2 and mGlu3 receptors along with concomitant increase in NMDA and Glt-1 transcript levels suggest no overall changes in glutamate homeostasis in the dHipp, and thus a habituation after 21-day CRS.
On the other hand, we found that changes in glutamate homeostasis after 21-day CRS observed in the whole hippocampus ( Figure 1A ) appear to be due to a dysregulation of the vHipp ( Figures 1F, 1G , 1J, and 1K), which is vulnerable to 21-day CRS. After CRS, we found strong downregulation of mGlu2 and mGlu3 receptors as well as of xCT exchangers; no changes were observed in the NR1/NMDA receptors and Glt-1 transporters ( Figure 1F ). These data show a remarkable sub-localization of changes along the dorso-ventral axis of the hippocampus, encouraging future studies targeted to investigate the d-and v-hippocampus as two different brain regions. Indeed, the study of the whole hippocampus masks some of the more specific stress effects.
In further regional detail, immunofluorescence and immunohistochemistry analyses, respectively, showed that xCT and mGlu2 protein levels were not altered by CRS in all three subregions of the dHipp (DG, CA3, and CA1) ( Figures 1H and 1I) , indicating agreement between mRNA and protein levels. In the ventral portion, CRS induced large decreases in xCT and mGlu2 immunoreactivity in the DG with no change in the CA3 and CA1 ( Figures 1G, 1J , and 1K). Both these findings strongly point to the importance of investigating the stress physiology within the tri-synaptic circuit (DG, CA3, CA1) of the hippocampus in addition to its dorso-ventral axis.
Downregulation of xCT ( Figure S3A ), an evolutionarily conserved protein, was also observed in the ventral dentate gyrus (vDG) of the transgenic mouse model BDNF Val66Met (BDNFhet)-a SNP common in the human population (Dincheva et al., 2012) . BDNFhet mice are characterized by reduced mGlu2 expression in the vDG and by an inherent (E) Enrichment pathway analysis shows that CRS affected several relevant signaling pathways within the vDG, including genes converging into the glutamatergic signaling (e.g., xCT: adj p value < 0.02, FC = 1.4 [p value <0.0005]), energy metabolism, inflammation, insulin pathway, calcium signaling, endocannabinoid and addiction pathways, and TrkB signaling cascade). Bars represent mean ± SEM, and asterisk indicates significant comparisons with corresponding controls, *p < 0.05, **p < 0.01 at Student's two-tailed t tests. See also Tables S1 and S2. susceptibility to depressive-like behaviors as showed by abnormal coping style at the FST and reduced social interactions ( Figures S3B and S3C) , supporting a critical role for xCT and mGlu2 in the vDG in stress resilience.
RNA-Seq of the Hippocampal vDG Provides Novel Markers of Response to Chronic Stress
Since the vDG has emerged from these findings as having a critical role in resilience to stress, we used RNA sequencing (RNAseq) to capture transcriptome-wide alterations in the vDG (Figure 2A ; Table S1 ) after a prolonged 21-day CRS as compared to not-stressed controls. CRS, which led to a loss of resilience and depressive-like behaviors, altered expression of 499 genes (adjusted-p < 0.15, fold change >1.3) with 254 downregulated and 245 upregulated genes ( Figure 2B ). Using enrichment and GO analyses, we found that CRS affected several relevant signaling pathways in the vDG (Figures 2D and 2E ; Table S2) with meaningful gene categories that include glutamatergic signaling, e.g., xCT, and mGlu2 transcripts as confirmed by subsequent qPCR validation on larger biological replicate cohorts ( Figure 2C ). Other meaningful gene categories included energy metabolism, inflammation, insulin pathways, calcium signaling, endocannabinoid and addiction pathways, and TrkB signaling cascades (Hill and McEwen, 2009; Ja sarevi c et al., 2015; Koob and Kreek, 2007; Rantam€ aki et al., 2007) , along with gene transcription regulators, such as the histone deacetylase enzyme-9 (HDAC-9) (Tsankova et al., 2006) (Figures 2D and 2E) .
Given the importance of histone acetylation (Nestler, 2014) in the regulation of gene expression, we thought that the change in HDAC9 could explain the decreased expression of xCT. RNA-seq analysis indicated that CRS results in a specific downregulation of HDAC-9 in the vDG (CC: 29.9 ± 2.6, CRS: 22.5 ± 0.7; adjusted-p < 0.13, p < 0.005, fold change = 1.33). However, this change is in the opposite direction from what would explain the decreased expression of xCT. Hence, we concluded that there may be a potential upstream mechanism in the responses to CRS that would lead to the observed decrease in xCT. Future studies are needed to investigate the contribution of HDAC gene expression in the stress-sensitive vDG. (I) SAS also blocked NAC effects in elevating xCT and mGlu2 transcript levels in the vDG of CRS mice (mRNA, xCT: F 2,16 = 6.28, p < 0.01; mRNA, mGlu2: F 2,11 = 7.92, p < 0.01). (J) Schematics featuring a mechanistic model in that stress, glucocorticoids, and glutamate interact each other in a gene network system to regulate adaptive brain plasticity. In pathological condition, stress activates a glutamate cascade with decrease in extracellular release of glutamate own to reduced expression of xCT in vDG and failure to provide glutamate to prime the nearby mGlu2 receptors with consequent suppression of mGlu2-mediated inhibition of neuronal glutamate release. This gene network system accounts for the overflow of glutamate in the synaptic space and underlying brain plasticity and maladaptive responses to stress with occurrence of depressive-like behaviors. Bars represent mean ± SEM, and asterisk indicates significant comparisons with corresponding controls, *p < 0.05, **p < 0.001, ***p < 0.0001. See also Figure S6 .
Double-ChIP Reveals an Epigenetic Mechanism of Full
Co-occupancy of H3K27ac and REST in the Regulation of xCT Previous studies have shown a role for the transcriptional repressor REST in the regulation of glutamate genes in response to environmental signals, including ischemic insults (Noh et al., 2012) . Here, we investigated the role of REST, which is expressed in xCT-positive cells ( Figure S4 ), in response to stress. Immunohistochemical approach showed that REST cell count was significantly increased in the vDG, but not in the ventral CA3 and CA1, after 21-day CRS ( Figure 3A ). Previous studies have also revealed direct functional interactions of stress-sensitive histone markers, such as H3K27ac, in the regulation of target genes of the glutamate synapse, including the Grm2 gene that encodes for mGlu2 receptors in response to stress. Therefore, we evaluated CRS effects on acetylation of H3K27 in the ventral hippocampus. We found that CRS-induced increase in REST expression was concomitant with a decreased acetylation of the histone marker H3K27 in the vDG ( Figures 3B and 3D ). Chromatin immunoprecipitation (ChIP) analyses also revealed a CRS-induced increased enrichment of REST and a decreased enrichment of H3K27ac on the xCT promoter ( Figure 3C ).
Given this concomitant pattern of changes, we reasoned that the gene expression regulators, REST and H3K27ac, could coregulate xCT expression. To test this hypothesis, we studied a possible combinatorial binding of the transcription factor REST with the histone marker H3K27ac, by combinatorial ChIP (Co-ChIP or double-ChIP) assay (Peng and Chen, 2013) for the xCT promoter gene in naive animals ( Figure 3E ). As shown by double-ChIP, REST and H3K27ac were co-enriched on the xCT promoter ( Figure 3F ). Notably, co-enrichment of REST and H3K27ac was observed to a much lower degree on the Grm2 promoter ( Figure S5 ), suggesting that xCT and mGlu2 expression are differently regulated, whereby a combinatorial mechanism with co-occupancy of REST and H3K27ac regulates xCT expression, whereas H3K27ac is sufficient to regulate mGlu2 without REST.
Role of the xCT-mGlu2 Interplay in Stress Resilience and Antidepressant Effects
Converging evidence from our and other laboratories has shown that normalization of glutamate homeostasis, through LAC-induced elevation of mGlu2 receptors, rapidly corrects mood abnormalities in several animal models (Nasca et al., 2013b; Lau et al., 2017; Cuccurazzu et al., 2013) . Previous studies have also shown that activation of mGlu2 receptors is boosted by the glial glutamate released from the xCT exchanger (Kalivas, 2009 ) to inhibit synaptic glutamate release. Since the results above revealed a key role of xCT in the stress-induced depressive-like behavior, we implemented a gain-of-function pharmacological approach using N-acetyl-cysteine (NAC), which targets xCT (Lewerenz et al., 2013) , to reinforce the endogenous activation of mGlu2 receptors. We also compared the profile of action of NAC with the histone acetylating agent LAC, a novel antidepressant candidate (Flight, 2013; Nasca et al., 2013b; Russo and Charney, 2013; Wang et al., 2014) , and with a reference selective serotonin reuptake inhibitor (SSRI) antidepressant, fluoxetine (Prozac) (Figures 4A and 4B) .
NAC-orally administered for 3 days prior to the end of CRS ( Figure 4B )-prevented the behavioral abnormalities induced by CRS at the FST and social interaction (SI) tests (Figures 4C and 4H) . Rapid pro-resilient effects were also observed with 3 days of oral treatment with the acetylating agent LAC (Figure 4C) , which is known to prevent CRS-induced impairments in SI (Lau et al., 2017) . In contrast, the SSRI fluoxetine did not prevent the depressive-like behavior associated with CRS over the same time course of administration ( Figure 4C ) in agreement with previous findings showing that longer time course of weeks of administration with fluoxetine to CRS mice are required to induce antidepressant-like effects (Dulawa et al., 2004; Nasca et al., 2014, Soc. Neurosci., abstract) .
Molecularly, NAC prevented the CRS-induced decrease in xCT transcripts and immunoreactivity in the vDG (Figures 4D and 4E) . NAC also prevented the CRS-induced increase in REST enrichment to the xCT promoter and the CRS-induced decrease in H3K27ac bound to the same promoter target (Figure 4F) . The NAC-induced rapid increase in acetylation of H3K27 and behavioral resilience is in agreement with the rapid behavioral effects induced by 3 days of oral administration of the acetylating agent LAC (Lau et al., 2017) (Figure 4C) . Thus, the enhancement of histone acetylation appears a key process for next-generation treatments to promote resilience to stress.
In vitro studies using cystine to activate xCT have shown that the glial glutamate released by xCT stimulates activation of (B-D) 3 days after the end of CRS, mice receiving water only showed an enduring stress-induced susceptibility to changes in copying style at the FST (B) and in SI (C) that were paralleled by an enduring xCT reduction in the vDG (D). Pharmacological treatment with NAC, orally administered for 3 days at the end of CRS, improved copying style at the FST (B) and SI (C), and elevated xCT expression in the vDG of CRS mice (D). Similar rapid antidepressant-like effects were observed using a pharmacological treatment with LAC, orally administered for 3 days at the end of CRS ( Figure S7 ). Bars represent mean ± SEM, and asterisk indicates significant comparisons with corresponding controls, *p < 0.05, **p < 0.001, ***p < 0.0001. See also Figure S7 . mGlu2 receptors (Kalivas, 2009) . To investigate whether the proresilient effect of NAC was related to xCT and to assess whether xCT pro-resilient action might involve a network that includes mGlu2 signaling, we investigated the consequence of pharmacologically blocking xCT by using sulphasalazine (SAS) (Bernabucci et al., 2012) . A single injection of SAS to CRS mice did not affect the immobility time at the FST and SI ratio in CRS mice ( Figure S6 ) but significantly reduced the pro-resilient effects of NAC in both the FST and SI tests (Figures 4G and 4H) . SAS also blocked NAC effects to prevent CRS-induced reductions in xCT and mGlu2 transcript levels in the vDG (Figure 4I) . Therefore, these findings suggest that xCT contributes to NAC pro-resilient effects and that NAC activates a negative feedback network with mGlu2 to limit glutamate overflow in the ventral hippocampus ( Figure 4J ).
Given that for clinical use, NAC may presumably be administered after stress occurred, we investigated the effects of NAC, administered after discontinuing the CRS paradigm ( Figure 5A ), on behaviors and xCT regulation. NAC-orally administered for 3 days at the end of CRS ( Figure 5A )-showed antidepressantlike effects at the FST and SI tests ( Figures 5B and 5C ), while also elevating xCT mRNA expression in the vDG ( Figure 5D ). Likewise, rapid antidepressant-like effects in the same behavioral tests were observed with 3 days of oral administration of LAC ( Figure S7 ). We note that, 3 days after the end of CRS, mice receiving water only showed an enduring stress-induced susceptibility to changes in coping style at the FST and in SI that were paralleled by an enduring xCT reduction in the vDG (Figures 5B-5D) .
To test the prediction that increased expression of xCT in vDG mediates pro-resilient effects in response to CRS, we developed herpes simplex viruses (HSVs) to overexpress xCT in the vDG in CRS mice ( Figure 6A ). We used a viral vector that allows for a short-term expression window to have temporal control of xCT overexpression and evaluated its effects on behaviors. HSVmediated xCT overexpression in the vDG of CRS mice ( Figures  S8A and S8B ) rescued the enhanced immobility time at the FST and the SI impairments ( Figures 6B and 6C ). Overexpression of xCT in the vDG also rescued the downregulation of mGlu2 receptors in vDG ( Figure 6D ), supporting the role of xCT as part of a network in promoting resilience to stress.
Next, given that CRS downregulated xCT specifically in GFAP + cells ( Figures 7A and 7B) , we developed Cre-dependent HSV vectors to overexpress xCT in a cellular and anatomical specific manner, that is in GFAP + (astroglial) cells within the vDG, in GFAP + -reporter mice after CRS ( Figure 7C ).
GFAP + -Cre-dependent overexpression of xCT in the vDG of CRS mice ( Figure S8C ) rescued the enhanced immobility time at the FST and the SI impairments ( Figures 7D and 7E) , proving a mechanistic role of the astroglial xCT in the vDG in resilience to stress.
DISCUSSION
Our findings reveal a previously unknown role for the astroglial marker xCT in the vDG in the homeostatic regulation of the glutamate system underlying resilience to stress and antidepressant responses. A novel epigenetic mechanism of gene regulation driven by a combinatorial action of REST and the histone marker H3K27ac regulates xCT, activity of which primes mGlu2 to enhance glutamate homeostasis. Our findings also support a key role for modulation of histone acetylation in promoting stress resilience and rapid antidepressant responses.
We demonstrate that studying the whole hippocampus masks some of the stress effects and supports future studies targeted to investigate the dorsal and ventral hippocampus as two different brain regions. This is particularly relevant in studies aimed at investigating stress neurobiology and antidepressant mechanisms of action as well as in other contexts in which glutamatergic transmission is dysregulated (e.g., Alzheimer's disease). In our study, xCT expression was differentially regulated in the dorsal and ventral hippocampus after CRS, which caused depressive-like behaviors. The CRS-induced decreased expression of xCT, which was narrowed to the ventral hippocampus, was not detected in the whole hippocampus. The dorsal and ventral hippocampus are known to project to different brain regions and, therefore, may activate different brain circuits in the responses to stress: e.g., the ventral-hippocampus projects to the prefrontal cortex, nucleus accumbens and amygdala (FelixOrtiz and Tye, 2014; Ishikawa and Nakamura, 2003) , which are all regions highly plastic in response to stress (Bagot et al., 2015; Lau et al., 2017; McEwen and Morrison, 2013) . Recent findings have shown that the same stress paradigm of 21-day CRS also affects brain plasticity in another mood-regulatory brain region, the medial amygdala (MeA) (Lau et al., 2017) . Given that LAC treatment prevents the CRS-induced impairments in the MeA (Lau et al., 2017) , and that our current findings show a LAC-induced upregulation of mGlu2 and xCT in the vDG of CRS mice, it will be important to investigate how the vDG interacts with the MeA in response to stress and to pharmacological treatments. The current study also provides an RNA-seq roadmap for the vDG that can serve for future studies aimed at discovering novel biological targets of stress susceptibility in a brain region that we and other investigators have shown is critical for stress and antidepressant responses.
The homeostatic regulation of the glutamate system in response to stress and to both pharmacological and viral-mediated manipulations reveal that, in the vDG, xCT promotes resilience and rapid antidepressant-like responses by acting synergistically with mGlu2 receptor, which is a known target of stress susceptibility and antidepressant action (Nasca et al., , 2013b . Such an mGlu2-xCT gene network is supported by previous in vitro studies showing that using cystine to activate the system xc-results in an xCT-driven release of glial glutamate that stimulates activation of mGlu2 receptors (Kalivas, 2009) , which, in turn, inhibits neuronal glutamate release. Moreover, an xCT and mGlu2 gene network was also shown to be involved in cocaine addiction. Indeed, the reduction in reinstated cocaine seeking elicited by activating xCT with NAC is prevented by pretreatment with an mGlu2/3 antagonist (Lewerenz et al., 2013) .
In agreement with these previous findings, our study shows that pharmacological treatment with NAC regulated responses to stress and depressive-like behaviors by increasing xCT expression and indirectly activating mGlu2 receptors. The fact that pharmacological blockade of the xc-system also blocked NAC effects on mGlu2 receptors further supports the linkage with mGlu2 regulation in promoting resilience to stress. Anatom- ical and astroglial-type specific overexpression of xCT in GFAP -positive cells in vDG also rescued the CRS-induced downregulation of mGlu2 receptors. These findings further supports a role of xCT as part of a glial-neuronal network involving mGlu2 receptors, and activation of mGlu2 receptors also contributes to promote resilience to stress.
Furthermore, previous studies have shown that mGlu2 receptors are downregulated by stress activation of mineralocorticoid receptors (MRs) in the hippocampus leading to depressive-like behavior (Karst et al., 2005; Nasca et al., 2015a) . Our current findings show that activation of xCT and mGlu2 gene expression network by NAC and LAC ameliorates stress actions and points to a mechanistic model of stress, glucocorticoids, and glutamate interactions with each other (Karst et al., 2005; McEwen et al., 2015a) in a biphasic gene network system to regulate response to stress ( Figure 4J ). Stress activation of MRs activates a glutamate cascade with overflow of synaptic glutamate due to an MR-induced downregulation of mGlu2 receptors .
Stress also downregulates xCT expression in the vDG with the consequent failure to provide glutamate to prime the nearby mGlu2 receptors and, therefore, further reduce mGlu2-mediated inhibition of neuronal glutamate release ( Figure 4J ). This gene network may account for a stress-induced overflow of glutamate underlying maladaptive brain plasticity and responses to stress with occurrence of depressive-like behaviors ( Figure 4J ). Using the same stress paradigm, previous studies have shown that CRS leads to remodeling of apical hippocampal dendrites (Magariñ os and McEwen, 1995) and suppression of neurogenesis , which are dependent upon excitatory amino acids acting synergistically with glucocorticoids (McEwen, 2007) .
Furthermore, our findings support the fact that buffering histone acetylation can be a viable strategy to promote stress resilience and rapid antidepressant responses with the use of next-generation therapeutic approaches, either drugs or natural biochemicals. In contrast to the rapid actions of histone acetylating agents like LAC and NAC on upregulation of mGlu2 expression (Nasca et al., 2014, Soc. Neurosci., abstract) , the antidepressant effects of fluoxetine require a more prolonged time course of administration to achieve the same result. Future studies are warranted to investigate whether the antidepressant effects of fluoxetine that involves mGlu2 upregulation (Nasca et al., 2014 , Soc. Neurosci., abstract) also activate xCT expression. Modulating histone acetylation with NAC promotes a mechanism of gene expression regulation that involves acetylation of H3K27 and release of the repressive transcriptional factor REST to activate xCT expression and indirectly mGlu2 receptors. An alternative strategy to buffer histone acetylation and, ultimately, promote rapid either stress resilience (Lau et al., 2017) or rapid antidepressant responses (Cuccurazzu et al., 2013; Wang et al., 2014; Wang et al., 2015; Nasca et al., 2013b) without the development of tolerance is with the use of LAC. LAC is a next-generation antidepressant candidate (Russo and Charney, 2013) that acts as an epigenetic modulator of glutamatergic function by targeting mGlu2 (Cuccurazzu et al., 2013; Nasca et al., 2013b) and also upregulating xCT expression in vDG.
Moreover, common pathways may underline the rapid actions of NAC and LAC. LAC supplementation has been shown to have metabolic actions, such as insulin-sensitizing actions, in rodents with depressive-like phenotypes (Bigio et al., 2016) . Likewise, previous studies have shown that NAC exert therapeutic effects on psychiatric disorders through its anti-inflammatory and metabolic actions (e.g., glutathione production) (Berk et al., 2013; Dean et al., 2011) . Hence, future studies are needed to further investigate linkage versus independence of NAC and LAC mechanisms of action upon glutamatergic regulation and anti-inflammatory/metabolic pathways. Previous studies have also shown that animals with depressive-like behavior and mGlu2 downregulation in the hippocampus are characterized by a LAC deficiency, which, recently was also shown to be a biomarker for major depressive disorder in humans (Nasca et al., 2017, Soc. Neurosci., abstract) . The current findings also raise the possibility that NAC rapid effects may increase LAC levels to indirectly activate mGlu2 receptors.
Taken together, our findings establish xCT in astroglial cells operating in a key brain region, the vDG, as part of a critical gene network system with mGlu2 receptors for promoting resilience to stress and rapid antidepressant-like actions via regulation of glutamate homeostasis. Our findings support the study of the dorsal and ventral hippocampus as two different brain regions. Moreover, our study provides a foundation for future studies of the pathophysiological role of glutamate homeostasis in a variety of disorders, including depression and Alzheimer's disease, in which glutamatergic signaling is dysregulated.
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Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Bruce McEwen (mcewen@mail.rockefeller.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All procedures were carried out in accordance with the National Institutes of Health and The Rockefeller University Institutional Animal Care and Use Committee guidelines. All efforts were made to minimize any potential animal suffering.
Male C57black 6N (7 week old, 20-25 g; Charles River), BDNF heterozygous Val66Met knockin mice (from an in-house breeding colony with breeding strategy BDNF heterozygous Val66Met X BDNF heterozygous Val66Met) and Gfap-Cre transgenic mice (backcrossed with C57black 6) were housed four per cage under controlled conditions (12-h light/dark cycle, 22 C, food and water ad libitum) and individually gently handled daily for 1 week before the beginning of the stress procedures. Adult mice were randomly assigned to experimental groups.
METHOD DETAILS
Stress Paradigms Naive mice were subjected to stress paradigms of different intensity and duration. Different groups of mice were subjected to 1, 7, 14 or 21 consecutive days of restraint stress. The restraint device contained two 0.4 cm air holes and allowed mice to stretch their legs but not to move within the tube. Effects of acute restraint stress (ARS) were evaluated 2hours after the end of the stress; effects of sub-chronic 7 and 14day stress (subCRS) as well as effects of chronic 21day stress (CRS) were evaluated 24hours after the end of the last episode of stress. Naive age-matched not-stressed animals were used as controls for each time point.
Pharmacological Preventive Approach NAC (N-acetyl-cysteine, Sigma Aldrich, A7250), LAC (acetyl-L-carnitine, Sigma Aldrich, A6706) and fluoxetine were orally administered. Drugs were dissolved in the drinking water and administered for 3 full days prior to the end of the chronic stress paradigm at a concentration of 0.3%, 0.3%, 0.05%, respectively. SAS (sulphasalazine) was injected i.p. at a dose of 8mg/kg based on previous reports (Bernabucci et al., 2012) . Saline was injected to additional groups as control for the SAS treated animals.
Additional animal groups were used to assure that the animals' fluid intake and hydration state were not altered by the oral NAC, LAC or fluoxetine administration. This was carried out evaluating the skin turgor, body weight as well as daily food and fluid consumption for 3 days. C57black 6N male mice in each of the treatment group showed a fluid intake with an average of 4,5ml per day per mouse as non-stressed control animals. For example, when housed 4 per cage, the fluid intake per cage show an average of about 18ml regardless of the stress and pharmacological treatment.
Pharmacological Treatment Approach NAC and LAC were orally administered, dissolving the drug in the drinking water for 3 full days at the end of the chronic stress paradigm at a concentration of 0.3%. Control CRS mice received water only. Fluid intake and hydration state were checked as above and not altered by treatments.
Behavioral tests
Forced swim test (FST), SI test and light-dark screening method were performed as previously described (Lau et al., 2017; Nasca et al., 2015a; Nasca et al., 2013a; Peñ a et al., 2017; Sato et al., 1999) . Forced Swim Test (FST) Two independent blind observers scored the total duration of immobility at the forced swim during a 6 min test. Mice were placed individually into a vertical glass cylinder (25 cm in height and 12 cm in diameter) filled with 12-cm deep water at 23-24
C. In each test session, animals were placed in the cylinder for 6 min and videotaped. Mice were considered 'immobile' if they showed only minimal movements to keep the head above water or floating. Social Interaction (SI) Mice were placed in an open-field arena (42 3 42 3 42 cm) with a small wire animal box (10 3 6.5 3 42 cm) placed at one side of the arena. Blind observers scored exploratory behavior for 2.5 min in the absence and presence of a CD-1 mouse in the small wire animal box with 1 min interval between the sessions. SI behavior was calculated as the ratio of the time spent in an interaction zone near the novel animal divided by the time spent in the same area near the empty box. Impairment in SI is defined by a ratio below 1.
Light-Dark Test (LDT)
The apparatus consisted of a rectangular Plexiglas box (20 3 50 3 20 cm) with a black chamber comprising 1\3 of the total volume. The two chambers were separated by a Plexiglas septum with an open door (12 3 5 cm) that permitted the passage from the illuminated chamber (400 lx) to the enclosed dark chamber (4 Ix). Mice were videotaped, and the time spent by each mouse in the light chamber was measured and scored by two independent blind observers. Mice were considered to have entered a chamber when all four paws were positioned into the chamber. No pretest (habituation session) was carried out before the test session.
GENE EXPRESSION ANALYSIS
After sacrifice by rapid decapitation, tissues were dissected, flash frozen, and stored at À80 C until processing. Tissue samples were weighed before homogenization and about 60-90mg of hippocampal tissue was lysed. Total RNA was extracted using Qiazol reagent and RNeasy mini Kit (QIAGEN, US), according to the manufacturer's instructions. RNA quality was checked using the 2100 Bioanalyzer (Agilent Technologies, US) and quantified spectrophotometrically. The acceptance criteria for RNA quality were a 260/280 ratio R 1.80 and % 2.20. 2mg of total RNA was then used for cDNA synthesis according to the manufacturer's instructions of the high capacity cDNA reverse transcription kit (Life Technologies, US). The reverse transcribed reaction was carried out according the follow condition steps: 25 C/10 min, 37 C/120 min and 85 C/5 min. qPCR was performed according to the protocols of the manufacturer (Life Technologies, US), using TaqMan Universal PCR Master Mix and gene-specific primers, synthetized by Applied Biosystem Company (Life Technologies, US). We validated our micro-dissection approach for isolating the dorsal and ventral hippocampus by examining the expression of a gene, lactase (LCT), which is known to be absent in the vDG. GAPDH was used as a reference control for qPCR analysis. The following PCR conditions were used: an initial incubation of 50 C for 2 min and a denaturation step of 95 C for 10 min, followed by 40 cycles of 95 C/15 s and 60 C/1 min. All reactions were performed in triplicate. The threshold cycle (CT), which correlates inversely with the levels of target mRNA, was measured as the number of cycles at which the reporter fluorescence emission exceeds the preset threshold level. The amplified transcripts were quantified using the comparative CT method with the formula for relative fold change = 2DDCT (Livak and Schmittgen, 2001 ).
SINGLE AND DOUBLE CHIP
Single ChIP was performed as previously described (Nasca et al., 2013b Nasca, 2015) using the Ez-Magna ChIP kit (Millipore, US) with few modifications to adapt the protocol to mouse brain tissue. Tissue was isolated from one hemisphere of a mouse brain. To fix the complexes DNA-proteins, hippocampal chopped tissues from each animal were incubated with 500 mL of PBS containing 1% formaldehyde in a rotator. After 10min the fixation reaction was stopped by adding 2M glycine. After cross-linking with formaldehyde, chromatin was sheared using the Covaris Ultrasonicator and fragments' size was confirmed in a 2% agarose gel. The ChIP validated antibodies for REST (3 mg, 6hrs incubation, Millipore cat.#CS200555) and H3K27ac (3 mg, 6hrs incubation, Abcam cat.#4729) were used to immunoprecipitate the material of interest. Input genomic DNA, REST-genomic DNA, and H3K27ac-genomic DNA were reverse cross-linked at 65 . Based on single ChIP with a single round of immunoprecipitation to detect binding of a single factor to target DNA fragments, we performed double-ChIP (Peng and Chen, 2013) with two sequential immunoprecipitation steps as shown in Figure 3E . Following the first immunoprecipitation for a protein of interest (REST or H3K27ac), enriched protein-DNA complex is eluted and subjected to a second round of immunoprecipitation for the second protein of interest (REST or H3K27ac). For our protein-pair of interest, REST and H3K27ac, two parallel double-ChIP were performed in reverse order for REST and H3K27ac. The results of two reciprocal double-qChIP were then compared with each single qChIP to determine full, partial, or no co-occupancy of the REST and H3K27ac on xCT and Grm2 promoters.
qPCR was used to quantify differential binding on the genomic DNA using custom-designed primers with following sequences: xCT promoter: Forward: GAGCGGAGCTGCTTAAA Reverse: CCTGTGGGTTGCTCAAT Probe: CCGGGACAGTGTCTATTCCCTGGTT Grm2 (mGlu2) promoter: Forward: GCCACTGTCTCATCTGTTCC Reverse: ATCCCGCTCTTGACAGGT Probe: ATTCAGCACCACACTGTGGACAGC b-actin promoter: Forward: GAGACATTGAATGGGGCAGT Reverse: ATGAAGAGTTTTGGCGATGG Probe: ACAAGGGCGGAGGCTATTCCTGTA Double-ChIP is a qualitative method to show co-occupancy of two regulatory proteins in the same promoter gene. In double-ChIP, when there is co-occupancy, the final enrichment is higher than the enrichment of individual ChIP for the proteins of interest and does not depend on the order of the individual ChIP. Co-occupancy is observed at a much lower degree when the final enrichment is lower than the enrichment of individual ChIP for the proteins of interest. Given the qualitative nature of the double-ChIP experiments, no statistics was run on this experiment.
RNASEQ AND BIOINFORMATICS ANALYSIS
4 mg of total RNA was used for mRNA library constructs, which were run on the bioanalyzer to verify the size and concentration before sequencing on the Illumina HiSeq2500 machine at the Genomic Core facility at the Rockefeller University. Animals with the same vulnerability were pooled together to yield the proper amount of RNA per sample. In total, three biological replicates were carried out for each condition. Each sample was provided with a unique adaptor and all samples were put in the same pool and sequenced with Illumina Hiseq2500 to yield the desired sequencing depth of about 30K. The Fastq files were evaluated for quality control using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and trimmed with Trimmomatic (Bolger et al., 2014) . Alignment was performed using the Tophat2 (Kim et al., 2013 ) against a reference gene database (GRCm38/mm10). Statistical analyses for Differential Expression (DE) were performed with EdgeR (Robinson et al., 2010) . A gene is considered differentially expressed when reaching the following criteria: FDR < 15% and FC > 1.3. Table S1 shows the sequencing data summary from quality control analysis; Table S2 reports the enrichment pathway analysis with the most significant pathways that are altered by prolonged 21day stress in the vDG. Enrichment pathways analysis was generated with KEGG (Kanehisa and Goto, 2000) .
IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMISTRY
For single, double, and triple immunofluorescence and immunohistochemistry, animals were sacrificed by deep anesthesia with pentobarbital (100mg/kg), followed by transcardially perfusion with heparinized saline and then 4% paraformaldehyde (PFA) using a peristaltic perfusion pump (Fisher Scientific, US). Brains were post-fixed for 4hrs in 4% PFA before sinking in 30% sucrose for 3 days. Finally, brains were flash freezing on dry ice and stored at À80 C until they were cut using microtome into 40mm-thick sections, which were then stored in a cryoprotectant solution at À20 C before being processed for immunofluorescence. Staining was carried out on 3-4 serial 40mm coronal sections from the rostrocaudal extent of the hippocampus (dorsal hippocampus: from À1.855 to À2.355 bregma; ventral hippocampus: from À2.98 to À3.28 bregma) as follow: sections were washed twice (2 3 15 min) in 0.1 M PBS solution (pH = 7.4), blocked in 0.5% BSA in 0.1 M PBS with 0.25% Triton X-100 for 30 min and, successively, incubated in the following primary antibodies: mGlu2 (1:500, Abcam), xCT (1:500, NovusBio cat.#NB300-318), REST (1:1000, overnight incubation, Millipore cat.#CS200555), Gfap (1:1000, Abcam cat#4674), CREB (1:1000, Abcam Ab31387), pCREB (1:500, SantaCruz cat.#sc-7978) overnight, GFP (1:500, Abcam), H3K27ac (1:1000, Abcam) at 4 C in the blocking solution. On the following day, sections were rinsed in 0.1 M PBS (3 3 10 min) before being incubated with secondary antibody (Alexa Fluor 647, Alexa Fluor 488 or Alexa secondary antibodies, 1:1000, 1hr) in the blocking solution for 30min. After three washes in 0.1 M PBS (3 3 10 min), brain sections were slide-mounted, coverslipped, and intensity was assessed using the Inverted TCS SP8 laser scanning confocal microscope.
For immunohistochemistry, sections were washed twice (2 3 15 min) in 0.1 M PBS solution (pH = 7.4), blocked in 0.5% BSA in 0.1 M PBS with 0.25% Triton X-100 for 30 min and, successively, incubated in the following primary antibodies: REST (1:1000, overnight incubation, Millipore cat.#CS200555), H3K27ac (1:1000, overnight incubation, Abcam cat.#4729) at 4 C in the blocking solution. On the following day, sections were rinsed in 0.1 M PBS (3 3 10 min) before being incubated with secondary antibody (1:1000, SantaCruz cat-sc-2370) in the blocking solution for 1hr. After three washes in 0.1 M PBS (3 3 10 min), tissues were incubated in the avidin-biotin peroxidase complex (Vector ABC Labs) for 30 min at RT followed by three more 10 min PBS washes. Subsequently, brain sections were randomly slide-mounted to avoid any difference among control and stressed groups in the peroxidase reaction, that was developed for 4 min using a diaminobenzidine (DAB) substrate (Sigma), followed by three brief PBS washes. Finally, the immunoreactivity for each coverslipped section was assessed by Nikon ECLIPSE 90i microscope, equipped with the digital camera DS-Fi1.
Data provided by the manufacturer shows that each antibody was at least 1,000-fold more selective for their specific mark versus other subunits. All antibodies were tested by blocking with their respective immunizing peptides to confirm their specificity. Immunoreactivity was also confirmed by control staining, which was performed without the primary and/or secondary antibodies.
For the purpose of the analysis, all groups were represented on each slide to avoid any difference in the DAB reaction. The image analysis was assessed on 3-4 sections per mouse by two independent observers in the following sub-regions: CA1, CA3 and dentate gyrus (DG) regions of the dorsal and ventral hippocampus. Densitometric analysis was accomplished using MCID (Imaging Research) software and a light box equipped with a CCD camera with a 60mm Nikon lens. Three-four sections per animal were examined and each region was analyzed across its full length (excluding transition zones between regions, e.g., CA2) and, after subtracting background (e.g., corpus callosum). The values for each region for each animal averaged to provide a single data point for that region and animal in relative optical density (arbitrary units). Cell count analysis was performed using the NIS-Elements software coupled to a Nikon ECLIPSE 90i microscope. Only cells clearly identified as REST-, CREB-pCREB-positive were systematically selected for quantification on both hemispheres. For the purpose of quantification, a rectangular region of interest (ROI) was outlined with a 2.5 mm 2 frame.
GENERATION OF VIRAL VECTORS FOR ANATOMICAL AND CELL-TYPE SPECIFICITY AND STEREOTAXIC SURGERY
All vectors used were cloned into p1005-HSV or LS1L-HSV. Herpes simplex virus (HSV) was chosen to manipulate gene expression based on its rapid expression within one-day post injection, maximal expression around days 3-5, and reduced expression there-after, being undetectable by day 7 (Peñ a et al., 2017) . HSV is neurotropic and posses multiple features that make it an ideal vector for gene manipulations in the brain and testing of in vivo behaviors. Viral construction and surgery were carried out according to standardized methods (Peñ a et al., 2017) . We overexpressed genes of interest using bicistronic p1005 HSV vectors expressing GFP alone or GFP and xCT (Sato et al., 1999) . GFP expression is driven by a cytomegalovirus (CMV) promoter, while the gene of interest is driven by the IE4/5 promoter. Viral vector expression was confirmed via qPCR and IF. We stereotaxically injected cre-viral vector (IE4/5 LS1L-xCT-mCMV) in the vDG of Gfap-Cre males to overexpress xCT selectively in astroglial cells (Gfap). The HSV-GFP-mCMV was used as control vector to prove the lack of effect due to virus alone. The Gfap-cre mice have been selected for these experiments because Gfap-Cre mice express cre-recombinase under the control of the Gfap promoter that is specific to glial cells. Stereotactic surgery was performed on mice that were anesthetized with a mixture of ketamine/xylazine using the Angle Two stereotaxic frame for mouse (Leica), a motorized injector (KDScientific, MA) and Hamilton syringes (30 gauge)(Hamilton, NV). Vectors were infused into the vDG with the following coordinates: AP:-3.46mm, ML: ± 2.17mm, DV: À2.46mm from Bregma. A total of 0.5 mL were infused bilaterally at a rate of 0.05 mL/min over 10 min; the needle was then kept in place for 5 min and slowly retracted over a period of 1 min to prevent backflow upon retraction. Coordinates were immunohistochemically confirmed in pilot mice to display vDG-restricted expression following surgery in separate cohorts upon the time-course of HSV expression. Spread of viruses from injection target was limited as documented previously for other HSVs and no spread of virus was observed in the nearby vCA3 region. Mice were returned to their home cages to recover from surgery on a warming pad and daily monitored.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using one-or two-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test, or the two-tailed unpaired Student's t tests. From 4 to 8 biological replicates have been used for the molecular analyses, unless otherwise indicated; and from 6 to 9 biological replicates have been used for the behavioral experiments.
DATA AND SOFTWARE AVAILABILITY
The RNA-seq data have been deposited in the GEO repository under ID code GEO: GSE103435.
